"kyowakirin" - Google News

Kyowa Kirin joins PhRMA, strengthening industry presence in D.C. - PhRMA

Mon, 22 Sep 2025 07:00:00 GMT

Kyowa Kirin joins PhRMA, strengthening industry presence in D.C. PhRMA

How many employees work at Kyowa Kirin, Inc.? - Revelio Labs

Wed, 06 May 2026 08:04:22 GMT

How many employees work at Kyowa Kirin, Inc.? Revelio Labs

Kyowa Kirin abandons touted eczema drug following safety review - BioPharma Dive

Tue, 03 Mar 2026 08:00:00 GMT

Kyowa Kirin abandons touted eczema drug following safety review BioPharma Dive

Kyowa Kirin and Kura initiate Phase II trial of ziftomenib for AML - Clinical Trials Arena

Mon, 27 Apr 2026 07:00:00 GMT

Kyowa Kirin and Kura initiate Phase II trial of ziftomenib for AML Clinical Trials Arena

Kura Oncology and Kyowa Kirin Present Promising Phase 1 KOMET-007 Results for Ziftomenib in Newly Diagnosed AML at EHA 2026 - Quiver Quantitative

Tue, 12 May 2026 07:00:00 GMT

Kura Oncology and Kyowa Kirin Present Promising Phase 1 KOMET-007 Results for Ziftomenib in Newly Diagnosed AML at EHA 2026 Quiver Quantitative

Kyowa Kirin Ends Late-Stage Rocatinlimab OX40 Development - Dermatology Times

Tue, 03 Mar 2026 08:00:00 GMT

Kyowa Kirin Ends Late-Stage Rocatinlimab OX40 Development Dermatology Times

Boehringer returns to Kyowa Kirin with €640M pact for preclinical autoimmune molecule - Fierce Biotech

Thu, 30 Oct 2025 07:00:00 GMT

Boehringer returns to Kyowa Kirin with €640M pact for preclinical autoimmune molecule Fierce Biotech

Amgen Ends Autoimmune Alliance With Kyowa Kirin Amid Safety, Efficacy Questions - BioSpace

Mon, 02 Feb 2026 08:00:00 GMT

Amgen Ends Autoimmune Alliance With Kyowa Kirin Amid Safety, Efficacy Questions BioSpace

Assessing Kyowa Kirin (TSE:4151) Valuation After Recent Share Price Softness And Mixed Return Profile - simplywall.st

Fri, 22 May 2026 06:07:18 GMT

Assessing Kyowa Kirin (TSE:4151) Valuation After Recent Share Price Softness And Mixed Return Profile simplywall.st

Japan's Kyowa Kirin to build research hub for strengthening drug discovery capabilities - BioSpectrum Asia

Tue, 12 May 2026 06:17:38 GMT

Japan's Kyowa Kirin to build research hub for strengthening drug discovery capabilities BioSpectrum Asia

Boehringer licenses autoimmune disease small molecule program | Boehringer Ingelheim US - Boehringer Ingelheim

Thu, 30 Oct 2025 07:00:00 GMT

Boehringer licenses autoimmune disease small molecule program | Boehringer Ingelheim US Boehringer Ingelheim

Kyowa Kirin to regain control of rocatinlimab development, commercialization - Yahoo Finance

Sat, 31 Jan 2026 08:00:00 GMT

Kyowa Kirin to regain control of rocatinlimab development, commercialization Yahoo Finance

Kyowa Kirin Announces Proposed Appointment of Abdul Mullick to President and Chief Executive Officer, While Former CEO Masashi Miyamoto to Remain Chairman - Business Wire

Thu, 11 Dec 2025 08:00:00 GMT

Kyowa Kirin Announces Proposed Appointment of Abdul Mullick to President and Chief Executive Officer, While Former CEO Masashi Miyamoto to Remain Chairman Business Wire

Values key to Kyowa Kirin’s commitment to transform lives of rare disease patients - The Pharma Letter

Wed, 08 Apr 2026 07:00:00 GMT

Values key to Kyowa Kirin’s commitment to transform lives of rare disease patients The Pharma Letter

Kyowa Kirin discontinues ongoing trials of rocatinlimab - Clinical Trials Arena

Wed, 04 Mar 2026 08:00:00 GMT

Kyowa Kirin discontinues ongoing trials of rocatinlimab Clinical Trials Arena

Is Kyowa Kirin (TSE:4151) Pricing Reflect Its Mixed Long Term Share Performance - simplywall.st

Sun, 17 May 2026 07:00:00 GMT

Is Kyowa Kirin (TSE:4151) Pricing Reflect Its Mixed Long Term Share Performance simplywall.st

Kyowa Kirin Could Get Windfall From Updated Newborn Screening Recommendations - BioSpace

Fri, 19 Dec 2025 08:00:00 GMT

Kyowa Kirin Could Get Windfall From Updated Newborn Screening Recommendations BioSpace

Kyowa Kirin secures FDA approval for Crysvita dosing update - Yahoo

Fri, 15 May 2026 07:00:00 GMT

Kyowa Kirin secures FDA approval for Crysvita dosing update Yahoo

Editor's Pick: The Small Pharma Approach to Innovation, with Kyowa Kirin - Fierce Pharma

Mon, 02 Feb 2026 08:00:00 GMT

Editor's Pick: The Small Pharma Approach to Innovation, with Kyowa Kirin Fierce Pharma

Fierce Pharma Asia—Kyowa ends OX40 program; Sanofi licenses first-in-class drug; BioNTech advances Duality ADC - Fierce Pharma

Fri, 06 Mar 2026 08:00:00 GMT

Fierce Pharma Asia—Kyowa ends OX40 program; Sanofi licenses first-in-class drug; BioNTech advances Duality ADC Fierce Pharma

Kyowa Kirin Axes Anti-OX40 Drug Due to Cancer Concerns - The Dermatology Digest

Wed, 04 Mar 2026 17:01:13 GMT

Kyowa Kirin Axes Anti-OX40 Drug Due to Cancer Concerns The Dermatology Digest

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML - Yahoo Finance

Fri, 24 Apr 2026 07:00:00 GMT

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML Yahoo Finance

AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS - PR Newswire

Mon, 08 Sep 2025 07:00:00 GMT

AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS PR Newswire

Kura and Kyowa Kirin secure FDA go-ahead for targeted leukaemia therapy - Pharmaceutical Technology

Fri, 14 Nov 2025 08:00:00 GMT

Kura and Kyowa Kirin secure FDA go-ahead for targeted leukaemia therapy Pharmaceutical Technology

Kyowa Kirin discontinues rocatinlimab trials due to safety issues - BioWorld News

Tue, 10 Mar 2026 07:00:00 GMT

Kyowa Kirin discontinues rocatinlimab trials due to safety issues BioWorld News

Amgen and Kyowa Kirin report preliminary outcomes from AD treatment trial - Clinical Trials Arena

Tue, 09 Sep 2025 07:00:00 GMT

Amgen and Kyowa Kirin report preliminary outcomes from AD treatment trial Clinical Trials Arena

Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program - Fierce Biotech

Fri, 30 Jan 2026 08:00:00 GMT

Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program Fierce Biotech

Kyowa's bet on Kura pays off as partners' oral med for AML subset wins FDA approval - Fierce Pharma

Thu, 13 Nov 2025 08:00:00 GMT

Kyowa's bet on Kura pays off as partners' oral med for AML subset wins FDA approval Fierce Pharma

Cancer risk scuppers Kyowa Kirin's autoimmune disease drug - pharmaphorum

Wed, 04 Mar 2026 08:00:00 GMT

Cancer risk scuppers Kyowa Kirin's autoimmune disease drug pharmaphorum

Assessing Amgen (AMGN) Valuation After Ending Kyowa Kirin Rocatinlimab Collaboration - Yahoo Finance

Mon, 02 Feb 2026 08:00:00 GMT

Assessing Amgen (AMGN) Valuation After Ending Kyowa Kirin Rocatinlimab Collaboration Yahoo Finance

Kyowa Kirin axes anti-OX40 drug after review flags Kaposi's sarcoma cases - FirstWord Pharma

Tue, 03 Mar 2026 08:00:00 GMT

Kyowa Kirin axes anti-OX40 drug after review flags Kaposi's sarcoma cases FirstWord Pharma

Grünenthal takes full ownership of JV with Kyowa Kirin - The Pharma Letter

Mon, 02 Mar 2026 08:00:00 GMT

Grünenthal takes full ownership of JV with Kyowa Kirin The Pharma Letter

Kyowa Kirin to regain control of rocatinlimab - The Pharma Letter

Sat, 31 Jan 2026 08:00:00 GMT

Kyowa Kirin to regain control of rocatinlimab The Pharma Letter

Kyowa Kirin Co., Ltd. Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next - simplywall.st

Sat, 09 May 2026 07:00:00 GMT

Kyowa Kirin Co., Ltd. Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next simplywall.st

Boehringer licenses Kyowa Kirin's small molecule for autoimmune disease - BioWorld News

Tue, 04 Nov 2025 08:00:00 GMT

Boehringer licenses Kyowa Kirin's small molecule for autoimmune disease BioWorld News

Kyowa Kirin reveals side effect in trial; GSK was lone bidder for RAPT - Endpoints News

Mon, 02 Feb 2026 08:00:00 GMT

Kyowa Kirin reveals side effect in trial; GSK was lone bidder for RAPT Endpoints News

Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML - PharmExec.com

Fri, 14 Nov 2025 08:00:00 GMT

Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML PharmExec.com

Amgen gives up on its once-prized eczema drug - BioPharma Dive

Fri, 30 Jan 2026 08:00:00 GMT

Amgen gives up on its once-prized eczema drug BioPharma Dive

Did Kyowa Kirin's (TSE:4151) New NPM1‑Mutated AML Trial Just Reframe Its Oncology Ambitions? - simplywall.st

Tue, 05 May 2026 07:00:00 GMT

Did Kyowa Kirin's (TSE:4151) New NPM1‑Mutated AML Trial Just Reframe Its Oncology Ambitions? simplywall.st

Kyowa Kirin halts rocatinlimab trials after safety signal - The Pharma Letter

Wed, 04 Mar 2026 08:00:00 GMT

Kyowa Kirin halts rocatinlimab trials after safety signal The Pharma Letter

How Abdul Mullick Is Leading Kyowa Kirin’s Global Transformation - Citeline News & Insights

Wed, 05 Nov 2025 08:00:00 GMT

How Abdul Mullick Is Leading Kyowa Kirin’s Global Transformation Citeline News & Insights

Kyowa Kirin Discontinues Rocatinlimab Trials Due To Malignancy Risk - Citeline News & Insights

Tue, 03 Mar 2026 08:00:00 GMT

Kyowa Kirin Discontinues Rocatinlimab Trials Due To Malignancy Risk Citeline News & Insights

Kyowa Kirin Co., Ltd. And Kura Oncology, Inc. Advance Ziftomenib With Japan Phase 2 Trial In NPM1 Mutated AML - BioPharma APAC

Mon, 27 Apr 2026 07:00:00 GMT

Kyowa Kirin Co., Ltd. And Kura Oncology, Inc. Advance Ziftomenib With Japan Phase 2 Trial In NPM1 Mutated AML BioPharma APAC

Earnings call transcript: Kyowa Kirin Q2 2025 sees profit decline amid restructuring - Investing.com

Sun, 16 Nov 2025 08:00:00 GMT

Earnings call transcript: Kyowa Kirin Q2 2025 sees profit decline amid restructuring Investing.com

Amgen hands back eczema drug to Kyowa Kirin despite positive late-stage data - Pharmaceutical Technology

Mon, 02 Feb 2026 08:00:00 GMT

Amgen hands back eczema drug to Kyowa Kirin despite positive late-stage data Pharmaceutical Technology

New cancer cases prompt Kyowa to discontinue late-stage autoimmune disease program - Fierce Biotech

Tue, 03 Mar 2026 08:00:00 GMT

New cancer cases prompt Kyowa to discontinue late-stage autoimmune disease program Fierce Biotech

Japan's Kyowa Kirin names Dr Abdul Mullick as President and Chief Executive Officer - BioSpectrum Asia

Fri, 12 Dec 2025 08:00:00 GMT

Japan's Kyowa Kirin names Dr Abdul Mullick as President and Chief Executive Officer BioSpectrum Asia

Kura and Kyowa Kirin seek to maintain ziftomenib momentum amid FDA review - The Pharma Letter

Mon, 29 Sep 2025 07:00:00 GMT

Kura and Kyowa Kirin seek to maintain ziftomenib momentum amid FDA review The Pharma Letter

Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace

Wed, 10 Sep 2025 07:00:00 GMT

Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful BioSpace

Kyowa Kirin : Transcript of Results Briefing Fiscal 2026 First Quarter - marketscreener.com

Fri, 15 May 2026 03:05:07 GMT

Kyowa Kirin : Transcript of Results Briefing Fiscal 2026 First Quarter marketscreener.com

Amgen and Kyowa Kirin announce rocatinlimab results for atopic dermatitis - PMLiVE

Tue, 16 Sep 2025 07:00:00 GMT

Amgen and Kyowa Kirin announce rocatinlimab results for atopic dermatitis PMLiVE

Kyowa Kirin Q2 2025 slides: profit falls 57% amid restructuring, pipeline advances - Investing.com

Sun, 16 Nov 2025 08:00:00 GMT

Kyowa Kirin Q2 2025 slides: profit falls 57% amid restructuring, pipeline advances Investing.com

First U.S. Commercial Sale of KOMZIFTI™ Triggers $135 Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin - Yahoo Finance

Tue, 02 Dec 2025 08:00:00 GMT

First U.S. Commercial Sale of KOMZIFTI™ Triggers $135 Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin Yahoo Finance

Fierce Pharma Asia—Amgen, Kyowa's OX40 divorce; Roche's RNAi deal; Daiichi's ADC cull - Fierce Pharma

Fri, 06 Feb 2026 08:00:00 GMT

Fierce Pharma Asia—Amgen, Kyowa's OX40 divorce; Roche's RNAi deal; Daiichi's ADC cull Fierce Pharma

Kura/Kyowa Kirin’s Komzifti Comes With QTc Safety Advantage - Citeline News & Insights

Thu, 13 Nov 2025 08:00:00 GMT

Kura/Kyowa Kirin’s Komzifti Comes With QTc Safety Advantage Citeline News & Insights

Kyowa Kirin Co., Ltd. Plans the Creation of State-Of-The-Art Research Hub - marketscreener.com

Wed, 06 May 2026 07:00:00 GMT

Kyowa Kirin Co., Ltd. Plans the Creation of State-Of-The-Art Research Hub marketscreener.com

Kyowa Kirin names Abdul Mullick as next CEO effective March 2026 - Investing.com

Thu, 11 Dec 2025 08:00:00 GMT

Kyowa Kirin names Abdul Mullick as next CEO effective March 2026 Investing.com

Senior European role for Aurélie-Anne Chausse at Kyowa Kirin - The Pharma Letter

Tue, 14 Oct 2025 07:00:00 GMT

Senior European role for Aurélie-Anne Chausse at Kyowa Kirin The Pharma Letter

Kyowa Kirin Q2 2025 slides: Revenue stable as profit falls amid restructuring - Investing.com

Tue, 14 Oct 2025 07:00:00 GMT

Kyowa Kirin Q2 2025 slides: Revenue stable as profit falls amid restructuring Investing.com

Amgen ends Rocatinlimab collaboration with Japan's Kyowa Kirin - BioSpectrum Asia

Wed, 04 Feb 2026 08:00:00 GMT

Amgen ends Rocatinlimab collaboration with Japan's Kyowa Kirin BioSpectrum Asia

Kyowa Kirin Co Ltd stock (JP3249600002): shares steady after recent earnings as investors assess val - AD HOC NEWS

Fri, 29 May 2026 17:31:35 GMT

Kyowa Kirin Co Ltd stock (JP3249600002): shares steady after recent earnings as investors assess val AD HOC NEWS

Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin - GlobeNewswire

Fri, 24 Oct 2025 07:00:00 GMT

Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin GlobeNewswire

Kyowa Kirin Co Ltd stock (JP3249600002): oncology and rare-disease focus after recent earnings updat - AD HOC NEWS

Sat, 16 May 2026 13:02:15 GMT

Kyowa Kirin Co Ltd stock (JP3249600002): oncology and rare-disease focus after recent earnings updat AD HOC NEWS

Kyowa Kirin names Abdul Mullick as next CEO effective March 2026 - Investing.com Australia

Thu, 11 Dec 2025 08:00:00 GMT

Kyowa Kirin names Abdul Mullick as next CEO effective March 2026 Investing.com Australia

Amgen (AMGN) And Kyowa Kirin Reveal Initial Results From Rocatinlimab ASCEND Study - simplywall.st

Wed, 10 Sep 2025 07:00:00 GMT

Amgen (AMGN) And Kyowa Kirin Reveal Initial Results From Rocatinlimab ASCEND Study simplywall.st

Metabolic marketing master maneuvers to CEO—Chutes & Ladders - Fierce Biotech

Fri, 12 Dec 2025 08:00:00 GMT

Metabolic marketing master maneuvers to CEO—Chutes & Ladders Fierce Biotech

Boehringer taps Kyowa's preclinical autoimmune candidate in €640M deal - FirstWord Pharma

Thu, 30 Oct 2025 07:00:00 GMT

Boehringer taps Kyowa's preclinical autoimmune candidate in €640M deal FirstWord Pharma

Boehringer Ingelheim acquires license of autoimmune drug from Japan's Kyowa Kirin for â‚¬ 640 M - BioSpectrum Asia

Mon, 03 Nov 2025 08:00:00 GMT

Boehringer Ingelheim acquires license of autoimmune drug from Japan's Kyowa Kirin for â‚¬ 640 M BioSpectrum Asia

Kyowa Kirin Announces Discontinuation of Rocatinlimab Clinical Trials - Toronto Star

Tue, 03 Mar 2026 08:00:00 GMT

Kyowa Kirin Announces Discontinuation of Rocatinlimab Clinical Trials Toronto Star

35-year Industry-Academic Partnership Yielding Groundbreaking Advances for Science and Patients Renews for Another Three Years Between La Jolla Institute for Immunology and Kyowa Kirin – lji.org - La Jolla Institute

Wed, 02 Apr 2025 07:00:00 GMT

35-year Industry-Academic Partnership Yielding Groundbreaking Advances for Science and Patients Renews for Another Three Years Between La Jolla Institute for Immunology and Kyowa Kirin – lji.org La Jolla Institute

Kyowa Kirin Co Ltd stock (JP3249600002): growth prospects after recent drug updates - AD HOC NEWS

Thu, 21 May 2026 12:29:22 GMT

Kyowa Kirin Co Ltd stock (JP3249600002): growth prospects after recent drug updates AD HOC NEWS

Kyowa Kirin Co Ltd stock (JP3249600002): biotech name in focus as AI deal and ETF inclusion highligh - AD HOC NEWS

Tue, 19 May 2026 20:57:52 GMT

Kyowa Kirin Co Ltd stock (JP3249600002): biotech name in focus as AI deal and ETF inclusion highligh AD HOC NEWS

Jouliana Sadek Joins the Kyowa Kirin North America Team as Associate Director, Medical Value Outcomes Liaison - Oncodaily

Mon, 25 Aug 2025 07:00:00 GMT

Jouliana Sadek Joins the Kyowa Kirin North America Team as Associate Director, Medical Value Outcomes Liaison Oncodaily

La Jolla Institute renews longtime collaboration with Kyowa Kirin, Inc. - La Jolla Institute

Tue, 18 Jan 2022 08:00:00 GMT

La Jolla Institute renews longtime collaboration with Kyowa Kirin, Inc. La Jolla Institute

Kura scores FDA okay for rival to Syndax's leukaemia drug - pharmaphorum

Fri, 14 Nov 2025 08:00:00 GMT

Kura scores FDA okay for rival to Syndax's leukaemia drug pharmaphorum

LJI and Kyowa Kirin launch immunology fellowship program - La Jolla Institute

Thu, 27 Jul 2023 07:00:00 GMT

LJI and Kyowa Kirin launch immunology fellowship program La Jolla Institute

Kyowa, Amgen and Sanofi back push to change websites that miss the mark on women's health - Fierce Pharma

Wed, 23 Jul 2025 07:00:00 GMT

Kyowa, Amgen and Sanofi back push to change websites that miss the mark on women's health Fierce Pharma

Kyowa Kirin Co Ltd stock (JP3249600002): CRYSVITA gains reimbursement in Canada - AD HOC NEWS

Thu, 14 May 2026 07:08:44 GMT

Kyowa Kirin Co Ltd stock (JP3249600002): CRYSVITA gains reimbursement in Canada AD HOC NEWS

Kyowa Kirin Co Ltd stock (JP3249600002): Exploring biotech leader's US market exposure - AD HOC NEWS

Tue, 12 May 2026 09:13:08 GMT

Kyowa Kirin Co Ltd stock (JP3249600002): Exploring biotech leader's US market exposure AD HOC NEWS

Orchard Therapeutics Awarded Innovation Passport Designation for OTL-201 in MPS-IIIA - Yahoo Finance UK

Thu, 30 Apr 2026 07:00:00 GMT

Orchard Therapeutics Awarded Innovation Passport Designation for OTL-201 in MPS-IIIA Yahoo Finance UK

Social Contribution Activities – Not Just Developing New Drugs Kyowa Kirin for Kirin's Pharmaceuticals - Kirin Holdings Company, Limited

Wed, 25 Jun 2025 07:00:00 GMT

Social Contribution Activities – Not Just Developing New Drugs Kyowa Kirin for Kirin's Pharmaceuticals Kirin Holdings Company, Limited

Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC - PR Newswire

Mon, 10 Jun 2024 07:00:00 GMT

Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC PR Newswire

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis - The Manila Times

Fri, 30 Jan 2026 08:00:00 GMT

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis The Manila Times

Kura Oncology - Fierce Pharma

Tue, 02 Sep 2025 17:20:23 GMT

Kura Oncology Fierce Pharma

Kyowa Kirin Designs New North American Headquarters to Accelerate Innovation, Collaboration, Culture - PR Newswire

Tue, 11 Jul 2023 07:00:00 GMT

Kyowa Kirin Designs New North American Headquarters to Accelerate Innovation, Collaboration, Culture PR Newswire

Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company - PR Newswire

Thu, 31 Oct 2024 07:00:00 GMT

Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company PR Newswire

Kyowa Kirin Announces a New Sustainable Business Strategy for the Asia-Pacific (APAC) Region - PR Newswire

Thu, 01 Aug 2024 07:00:00 GMT

Kyowa Kirin Announces a New Sustainable Business Strategy for the Asia-Pacific (APAC) Region PR Newswire

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias - PR Newswire

Wed, 20 Nov 2024 08:00:00 GMT

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias PR Newswire

Grünenthal takes full ownership of Grünenthal Meds, the joint venture established ... - Presseportal.ch

Mon, 02 Mar 2026 08:00:00 GMT

Grünenthal takes full ownership of Grünenthal Meds, the joint venture established ... Presseportal.ch

Kyowa Kirin acquires Orchard Therapeutics for $477.6m - Pharmaceutical Technology

Thu, 25 Jan 2024 08:00:00 GMT

Kyowa Kirin acquires Orchard Therapeutics for $477.6m Pharmaceutical Technology

Kyowa Kirin Integrates North America Businesses in Support of Company's 2030 Vision and Rapid Growth Trajectory - PR Newswire

Wed, 31 Mar 2021 07:00:00 GMT

Kyowa Kirin Integrates North America Businesses in Support of Company's 2030 Vision and Rapid Growth Trajectory PR Newswire

Boehringer Ingelheim deals thrice, ending week with $449M Kyowa Kirin tie up - Fierce Biotech

Fri, 05 Jan 2024 08:00:00 GMT

Boehringer Ingelheim deals thrice, ending week with $449M Kyowa Kirin tie up Fierce Biotech

DKSH and Kyowa Kirin Forge Strategic Partnership Across Asia-Pacific - PR Newswire

Mon, 05 Aug 2024 07:00:00 GMT

DKSH and Kyowa Kirin Forge Strategic Partnership Across Asia-Pacific PR Newswire

Kura partners with Kyowa Kirin to advance AML treatment - Pharmaceutical Technology

Thu, 21 Nov 2024 08:00:00 GMT

Kura partners with Kyowa Kirin to advance AML treatment Pharmaceutical Technology

Kyowa Kirin Appoints Pharma Industry Leader Steve Schaefer as President, North America to Manage Next Phase of Growth - PR Newswire

Tue, 11 Apr 2023 07:00:00 GMT

Kyowa Kirin Appoints Pharma Industry Leader Steve Schaefer as President, North America to Manage Next Phase of Growth PR Newswire

Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands - NTB Kommunikasjon

Mon, 02 Mar 2026 08:00:00 GMT

Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands NTB Kommunikasjon

Kyowa Kirin will build $530M Research Triangle Park biologics facility - Manufacturing Dive

Fri, 14 Jun 2024 07:00:00 GMT

Kyowa Kirin will build $530M Research Triangle Park biologics facility Manufacturing Dive

Kyowa Kirin looks to cut small molecule research and manufacturing jobs, slims down in Asia - Fierce Pharma

Thu, 01 Aug 2024 07:00:00 GMT

Kyowa Kirin looks to cut small molecule research and manufacturing jobs, slims down in Asia Fierce Pharma

Kyowa Kirin Biologics Manufacturing Plant, North Carolina, USA - Pharmaceutical Technology

Fri, 28 Jun 2024 07:00:00 GMT

Kyowa Kirin Biologics Manufacturing Plant, North Carolina, USA Pharmaceutical Technology

Kyowa Kirin enrolls first patient in phase 2 trial of drops for treatment of diabetic macular edema - Ophthalmology Times

Fri, 09 Feb 2024 08:00:00 GMT

Kyowa Kirin enrolls first patient in phase 2 trial of drops for treatment of diabetic macular edema Ophthalmology Times